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Temperature sensitivityWest Nile virus NS4B is a small hydrophobic nonstructural protein approximately 27 kDa in size whose
function is poorly understood. Amino acid substitutions were introduced into the NS4B protein primarily
targeting two distinct regions; the N-terminal domain (residues 35 through 60) and the central hydrophobic
domain (residues 95 through 120). Only the NS4B P38G substitution was associated with both temperature-
sensitive and small-plaque phenotypes. Importantly, this mutation was found to attenuate neuroinvasiveness
greater than 10,000,000-fold and lower viremia titers compared to the wild-type NY99 virus in a mouse
model. Full genome sequencing of the NS4B P38G mutant virus revealed two unexpected mutations at
NS4B T116I and NS3 N480H (P38G/T116I/N480H), however, neither mutation alone was temperature sensi-
tive or attenuated in mice. Following incubation of P38G/T116I/N480H at 41 °C, ﬁve mutants encoding com-
pensatory substitutions in the NS4B protein exhibited a reduction in the temperature-sensitive phenotype
and reversion to a virulent phenotype in the mouse model.
© 2011 Published by Elsevier Inc.Introduction
West Nile virus (WNV) is a mosquito-transmitted member of
the genus Flavivirus, family Flaviviridae. This genus includes other
mosquito-borne viruses of public health importance: yellow fever
virus (YFV), Japanese encephalitis virus (JEV), and the four dengue
viruses (DENV-1–DENV-4). The WNV genome is a single-stranded,
positive-sense RNAmolecule approximately 11 kb in length encoding
a single polyprotein that is co- and post-translationally cleaved by a
combination of viral and host proteases to produce three structural
(C, prM, and E) and seven nonstructural (NS) proteins (NS1, NS2A,
NS2B, NS3, NS4A, NS4B, and NS5) (Brinton, 2002; Mukhopadhyay et
al., 2005). While two of the nonstructural proteins, the NS5 polymer-
ase and NS3 protease, have been relatively well-characterized, the
structure and function of the remaining nonstructural proteins, NS1,, University of Texas Medical
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sevier Inc.NS2A, NS2B, NS4A, and NS4B, remain poorly deﬁned (Khromykh
et al., 1999; Mastrangelo et al., 2007). Within the family Flaviviridae,
WNV NS4B exhibits approximately 35% amino acid identity with
other mosquito-borne ﬂaviviruses (Umareddy et al., 2006), such as
YFV and members of the DENV serogroup (Fig. 1A). Amino acid
identities are higher with more closely related viruses such as St.
Louis encephalitis virus (SLEV) and JEV with values of 56% and 65%,
respectively. The most genetically divergent WNV isolate, known
as Rabensburg virus, displays 88% amino acid identity with NY99
WNV in NS4B (Bakonyi et al., 2005). Accumulation of NS4B in the
perinuclear region along with induction of membrane proliferation
has been described in WNV (subtype Kunjin)-infected cells, and
there is evidence that NS4B can translocate into the nucleus
(Westaway et al., 1997). Flaviviral NS4B was also found to inhibit
the interferon-signaling cascade at the level of nuclear STAT phos-
phorylation and has been implicated in modulation of the stress-
induced unfolded protein response (Ambrose and Mackenzie,
2011; Munoz-Jordan et al., 2003, 2005). Amino acid residues in
the N-terminal region of the WNV NS4B protein have been shown
to control interferon resistance in HeLa cells expressing subgenomic
replicons, although no effect was shown on the expression of full-
length infectious genomes (Evans and Seeger, 2007). NS4B has
also been found to co-localize with other components of the viral
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et al., 2006). Sequential processing of the 2 K signal fragment
between the NS4A and NS4B proteins is thought to be critical for
the induction of cytoplasmic membrane alterations allowing for rep-
lication complex formation and maturation of individual proteins
(Miller et al., 2007; Preugschat and Strauss, 1991; Roosendaal et al.,
2006). Secondary structure predictions of the ﬂavivirus NS4B protein
generated by the consensus ConPredII hydrophobicity plotting
program suggest that it is a very hydrophobic protein with ﬁve
transmembrane domains (Arai et al., 2004) (Fig. 1B). Experimental
evidence suggests that there are three membrane-spanning
domains in the DENV-2 NS4B protein that are capable of targeting
a cytosolic marker protein to intracellular membranes while the
two N-terminal putative trans-membrane domains predicted by
some computer programs may not be biologically signiﬁcant (Miller
et al., 2006).
Previous studies have described mutations in the NS4B protein
of attenuated or passage-adapted mosquito-borne ﬂaviviruses, in-
cluding WNV (Davis et al., 2004; Puig-Basagoiti et al., 2007), suggest-
ing that this protein plays an important role in replication and
pathogenesis. In the case of other ﬂaviviruses, a single coding muta-
tion (P101L) in DENV-4 NS4B conferred a small-plaque phenotype
in Aedes albopictus (C6/36) cells, while at the same time increasing
plaque size in mammalian Vero and Huh-7 cells two-fold and three-
fold, respectively, when assayed via immunoperoxidase staining
(Hanley et al., 2003). Subsequent studies have suggested that
DENV-4 NS4B interacts with the NS3 protease and that the P101L
substitution ablates this interaction (Umareddy et al., 2006). Pletnev
et al. described DENV-4 NS4B T105I and L112S substitutions that oc-
curred in a chimeric virus expressing WNV structural proteins in a
DENV-4 backbone (Pletnev et al., 2002). Blaney et al. identiﬁed a
NS4B L112F mutation in a DENV-4 passaged in Vero cells, while the
live attenuated JEV vaccine strain SA14-14-2 has an I106V substitu-
tion in NS4B (Blaney et al., 2003; Ni et al., 1995). A hamster viscero-
tropic Asibi strain of YFV, generated by seven passages through
hamsters, accumulated seven amino acid substitutions in the poly-
protein, including a V98I substitution in NS4B (McArthur et al.,
2003). Interestingly, YFV vaccine strains also display a mutation in
NS4B at I95M (Hahn et al., 1987; Wang et al., 1995). When the
NS4B proteins from different ﬂaviviruses are aligned, it becomes
clear that these mutations are all located in a similar central hydro-
phobic region of the protein (Fig. 1A).
In this study, amino acid substitutions were engineered into ei-
ther the central hydrophobic region of the WNV NY-99 strain NS4B
protein or an N-terminal motif that is highly conserved in both
tick-borne and mosquito-borne ﬂaviviruses. In total, eight amino
acid substitutions were engineered into distinct regions of the
WNV NS4B protein. While most mutations had no detectable effect
on the phenotypic properties examined, the mutant containing a
P38G substitution was found to confer a small-plaque phenotype
in cell culture and attenuation of the neuroinvasive phenotype in
mice.
Results
Design of amino acid substitutions
The alignment in Fig. 1A shows a series of highly conserved amino
acids in the N-terminal portion of NS4B from both mosquito- and
tick-borne ﬂaviviruses. For WNV these residues corresponded to
D35, P38, W42, and Y45. TheW42 and Y45 residues are perfectly con-
served in all mosquito- and tick-borne ﬂaviviruses based on available
sequence data. The D35 residue is found in every mosquito- or tick-
borne ﬂavivirus examined except for the Brazilian mosquito-borne
ﬂaviviruses Ilheus and Rocio, which encoded an alanine and glutamic
acid residue, respectively (Kuno and Chang, 2005). The P38 residue isconserved in every ﬂavivirus examined except for Ilheus virus, which
encoded an alanine at this residue. Utilizing the ConPredII consensus
topology modeling program, the WNV P38 residue is predicted to re-
side near the junction of an endoplasmic reticulum lumenal and
transmembrane domain (Arai et al., 2004). To determine the impor-
tance of these residues in viral multiplication and virulence pheno-
types, D35E, P38G, W42F, and Y45F mutations were engineered into
the WNV NS4B protein via site-directed mutagenesis of an infectious
clone. Amino acid substitutions were selected on the basis of a combi-
nation of either conservative substitutions or substitutions identiﬁed
in one or more strains of different ﬂaviviruses at the speciﬁc residue.
Previous studies have described amino acid substitutions in a cen-
tral hydrophobic region of NS4B in either attenuated or passage-
adapted ﬂavivirus strains (Hanley et al., 2003; McArthur et al.,
2003; Wicker et al., 2006). Examination of alignments of various ﬂa-
viviral NS4B amino acid sequences (Fig. 1A), revealed that these mu-
tations all localized to a distinct region, residues 95–120. While amino
acid identities of ﬂaviviruses were variable in this region, there was a
high concentration of hydrophobic residues, suggesting that some of
these residues may interact with intracellular membranes. Amino
acid substitutions in WNV NS4B were engineered at homologous po-
sitions corresponding to published ﬂaviviral NS4B mutations. WNV
L97M and A100V substitutions corresponded to mutations identiﬁed
in attenuated (M95I) or passage adapted (V98I) YFV strains (Hahn
et al., 1987; McArthur et al., 2003; Wang et al., 1995). In addition,
the engineered WNV NS4B L108P substitution was homologous to
the DENV-4 P101L mutation found to confer a selective advantage
in mammalian Vero and Huh7 cells (Hanley et al., 2003). Thus, re-
combinant WN viruses were produced containing individual L97M,
A100V, and L108P mutations to determine if mutations associated
with attenuation of other ﬂaviviruses conferred attenuation of either
cellular multiplication or mouse virulence phenotypes in WNV. A
T116I substitution was also introduced following the identiﬁcation
of this additional mutation in a recombinant virus encoding a
designed P38G substitution to determine its role in observed viral
phenotypes.Rescue of recombinant viruses
Utilizing site-directed mutagenesis and the two-plasmid infec-
tious clone of WNV NY99 (Beasley et al., 2005; Kinney et al., 2006),
mutant viruses containing either D35E, P38G, W42F, Y45F, L97M,
A100V, L108P, or T116I substitutions in the NS4B protein were res-
cued following transfection of Vero cells. Sequencing of the NS4B re-
gion of recombinant viruses was conducted to conﬁrm the presence
of the mutation of interest. No other nucleotide changes were identi-
ﬁed in any virus, except for P38G virus. Virus stocks produced from
the initial transfection were used for all subsequent studies with the
exception of this P38G virus. Following multiple transfection experi-
ments, titers of P38G virus were not sufﬁciently high (approximately
2 log10 pfu/mL) for subsequent studies, so this virus was passaged
once in Vero cells. Upon sequencing of the NS4B region, the P38G
virus was found to contain additional NS4B T116I and NS3 N480H
substitutions that were not present in the original DNA plasmid, so
this virus will henceforth be denoted as P38G/T116I/N480H. A single
T116I or N480H substitution was engineered into the WNV infectious
clone to test the relative contribution towards observed phenotypes
of this mutation outside the context of the P38G mutation. The
T116I mutant displayed a plaque phenotype similar to wild type
virus. The P38G/T116I/N480H mutant virus was found to exhibit a
small-plaque phenotype when compared to wild-type or other mu-
tant viruses (less than 1 mm versus 4 mm for the parental virus)
(data not shown). The N480H mutant displayed an intermediate
plaque phenotype compared to the NY99 wild type and P38G/
T116I/N480H viruses.
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Fig. 1. Primary amino acid sequence of NS4B proteins from different ﬂaviviruses and predicted secondary structure of WNV NS4B. (A) Complete NS4B amino acid alignments
including both tick-borne and mosquito-borne ﬂaviviruses show locations of introduced substitutions in the conserved N-terminal region (D35E, P38G, W42F, Y45F) and central
hydrophobic domain (L97M, A100V, L108P, T116I). Virus abbreviations: WNV: West Nile NY99 strain (NC_009942); KUNV: Kunjin (AY274504); RABV: Rabensburg
(AY765264); JEV: Japanese encephalitis (NC_001437); MVEV: Murray Valley encephalitis (NC_000943); USUV: Usutu (NC_006551); SLE: St. Louis encephalitis (NC_007580);
ILHV: Ilheus (NC_009028); ROCV: Rocio (AY632542); DEN1: dengue 1 (NC_001477); DEN2: dengue 2 (NC_001474); DEN3: dengue 3 (NC_001475); DEN4: dengue 4
(NC_002640); YFV: yellow fever Asibi strain (AY640589); LGTV: Langat (NC_003690); OHFV: Omsk hemorrhagic fever (NC_005062); TBEV: Tick-borne encephalitis
(NC_001672); POWV: Powassan (L06436). (B) A topological model was constructed based on the consensus prediction (ConPredII) hydrophobicity plotting program (Arai et al.,
2004). Five transmembrane domains were predicted, and amino acids 106–126 represent the primary transmembrane domain (green). Predicted locations of introduced N-
terminal substitutions are shown in purple while introduced central hydrophobic substitutions are shown in orange. Positions of additional compensatory substitutions (A83S,
A95T, A100V, V110A, I224V) observed in the P38G/T116I/N480H virus incubated at 41 °C are shown in yellow. *A100V and T116I substitutions were introduced as central hydro-
phobic substitutions but also represent compensatory substitutions following introduction of the P38G substitution.
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viruses in cell culture
Each recombinant mutant virus was investigated for temperature
sensitivity by plaquing in Vero cells at both 37 °C and 41 °C. D35E,
W42F, Y45F, L97M, A100V, L108P, T116I, and N480H mutant viruses
and wild-type all showed similar levels of plaquing efﬁciency at
both temperatures (Table 1). In contrast, the P38G/T116I/N480H
virus was found to exhibit a 3.8 log10 pfu reduction in efﬁciency of
plaquing at 41 °C compared to 37 °C (Table 1A) while there was no
reduction in plaquing efﬁciency in Vero cells at 39.5 °C (data not
shown).
Multiplication curves of wild-type WNV NY-99 and the mutant
viruses were compared at a moi of 0.01 in Vero cells at both 37 °C
and 41 °C (Fig. 2). In addition, multiplication curves of recombinant
viruses in mouse neuroblastoma Neuro2A at 37 °C and mosquito
C6/36 cells at 28 °C were undertaken (data not shown). All mutant
viruses were indistinguishable from wild-type virus in each cell line
tested with the exception of the P38G/T116I/N480H virus. The P38G/
T116I/N480H virus exhibited a signiﬁcant delay in multiplication in
Vero cells at 41 °C, but not at 37 °C (Figs. 2A and 2C). Infectivity titers
for the P38G/T116I/N480H virus at 41 °C were also signiﬁcantly lower
than those for wild-type virus at every time point except 96 h. The
P38G/T116I/N480H virus showed no differences in multiplication
kinetics from wild-type virus in Neuro2A and C6/36 cells at the tem-
peratures tested (data not shown).P38G/T116I/N480H virus is attenuated for neuroinvasiveness but not
neurovirulence in mice
We have previously described a mouse model to investigate
neuroinvasiveness and neurovirulence of WNV via inoculation of
3–4 week-old female NIH Swiss mice intraperitoneally (ip) or intra-
cerebrally (ic), respectively (Beasley et al., 2002). With the exception
of the P38G/T116I/N480H virus, all recombinant viruses were as
virulent as wild-type WNV following ip inoculation in terms of
lethality and average survival time (Table 1). The P38G/T116I/
N480H mutant was attenuated for neuroinvasiveness with an ip
LD50 value of greater than 10,000 pfu. However, when inoculated
via the ic route, the P38G/T116I/N480H mutant remained as lethal
as wild-type WNV with an ic LD50 value of less than 0.1 pfu.
The P38A substitution maintained a neuroinvasive phenotype in mice
Following identiﬁcation of the attenuated P38G/T116I/N480H
virus, a P38A amino acid substitution was introduced into the WNV
infectious clone to better elucidate the importance of the P38 residue
in the absence of other amino acid mutations. The P38 residue is
conserved in both mosquito- and tick-borne ﬂaviviruses except
for Ilheus virus, which encoded an alanine at this residue (Fig. 1A).
Recombinant mutant WNV encoding the P38A substitution was not
temperature sensitive and exhibited a mouse neuroinvasive pheno-
type comparable to wild-type WNV (Table 1A).
Table 1
Mouse virulence and temperature sensitive phenotypes of recombinant wild-type WNV, the central hydrophobic mutants, and the N-terminal mutants (A) and the recombinant
wild-type WNV, attenuated P38G/T1161/N480H and N480H (B).
Virusc Mouse virulencea Temperature sensitivityb
i.p. LD50 (pfu) i.p. AST
(days±SD)
i.c. LD50 (pfu) Viral titer/mL at
37 °C (log10 pfu)
Viral titer/mL at
41 °C (log10 pfu)
Relative change in viral titer
[log10 (pfu 41 °C/pfu 37 °C)]
A
NY99 0.5 7.4±0.9 b0.1 6.5 6.7 −0.2
D35E 0.4 7.2±0.9 n.d. 5.7 5.4 −0.3
P38G/T116I/N480H >10,000 >35 b0.1 6.2 2.4 −3.8
W42F b0.1 7.4±0.9 n.d. 6.7 6.5 −0.2
Y45F b0.1 7.4±0.9 b0.1 5.5 5.8 0.3
L97M 0.4 7.6±1.0 n.d. 6.5 6.8 0.3
A100V 0.7 7.2±0.4 n.d. 7.0 6.7 −0.3
L108P b0.1 7.6±1.5 n.d. 6.8 7.0 0.2
T116I 0.7 8.0±1.8 n.d. 6.9 7.0 0.1
P38A 7 8.6±1.5 n.d. 5.8 5.6 −0.2
B
NY99 80 8.3±0.5 n.d. 7.2 7 0.2
N480H 20 8.2±0.5 n.d. 6.5 6 0.5
P38G/T1161/N480H >100,000 >18 n.d. n.d n.d n.d.
n.d.=not done.
a Median lethal viral dose (LD50) or median protective viral dose (PD50) following intraperitoneal (i.p.) or intracerebral (i.c.) administration of virus. AST=average survival time.
b Virus seeds were plaque titrated in Vero cells under agar overlay at 37 °C and 41 °C. The relative change [log10 (titer at 41 °C/titer at 37 °C)] in viral titer at the higher
temperature indicates the degree of temperature sensitivity.
c Infectious clone-derived wild-type WNV, strain NY99, central hydrophobic mutants, and N-terminal mutants in NS4B were tested. D35E=aspartic acid-to-glutamic acid mu-
tation at amino acid residue NS4B-38.
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Multiplication kinetics were compared in mice following ip inocu-
lation of either 100 pfu wild-type WNV or 100 pfu P38G/T116I/
N480H mutant in the NIH Swiss mouse model to determine serum
and brain infectivity titers for these viruses. The peak viremia for
wild-type WNV occurred on day 2 post-inoculation and reached 5.0Fig. 2. Multiplication kinetics of recombinant wild-type and N-terminal or central hydroph
MOI of 0.01, and the limit of detection was ≤0.7 log10 pfu/mL. N-terminal (A) and central h
(D) mutants in Vero cells at 41 °C.log10 pfu/mL, while the peak titer for the P38G/T116I/N480H virus
was 3.1 log10 pfu/mL, also on day 2 post-inoculation (Table 2). Peak
brain titers reached 6.8 log10 pfu for the wild-type virus on day 6
post-inoculation while virus infection was never detected in the
brains of P38G/T116I/N480H infected mice. The limit of detection
was 1.7 log10 pfu/mL for serum and 2.7 log10 pfu/brain for the brain.
RT-PCR ampliﬁcation was conducted on RNA isolated from mouseobic mutant viruses in monkey kidney Vero cells. Growth curves were conducted at a
ydrophobic (B) mutants in Vero cells at 37 °C, N-terminal (C) and central hydrophobic
Table 2
Viremia and brain titers from mice inoculated with 100 pfu of either wild-type WNV or
P38G/T116I/N480H mutant virus via the intraperitoneal route.
Day NY99 ip serum
(log10 pfu/mL)
Brain titer
(log10 pfu/brain)
P38G/T116I ip serum
(log10 pfu/mL)
Brain titer
(log10 pfu/brain)
1 4.1±0.9 –a 2.5±0.3 –
2 5.0±0.5 – 3.1±0.2 –
3 2.5±0.3 – 2.3±0.6 –
4 2.1±0.1 4.3±0.3 2.0b –
5 – 5.1±0.8 – –
6 – 6.8±0.6 – –
a No virus detected. The limits of detection were 1.7 log10pfu/mL in the serum and
2.7 log10pfu/brain.
b Only one of three mice had detectable infectivity.
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the brain. No PCR product was detected for WNV RNA from brains
of mice infected with P38G/T116I/N480H virus, while the brains of
mice infected with wild-type virus were positive for viral RNA (data
not shown). Thus, while the P38G/T116I/N480H virus exhibited
detectable serum infectivity titers, there was no evidence the virus
ever invaded the brain.
Isolation of P38G/T116I/N480H derivatives encoding compensatory
mutations
As shown in Fig. 2C, the P38G/T116I/N480H virus exhibited
delayed multiplication in Vero cells at 41 °C with infectivity titers ﬁ-
nally approaching those of wild-type virus by 96 h post-infection.
Given that a pattern characteristic of delayed multiplication was ob-
served, a virus sample from the 96-hour time point was investigated
to test for the selection of virus that was either a revertant or
contained compensatory mutations. Serial dilutions of P38G/T116I/
N480H-derived virus grown in Vero cells at 41 °C from the 96-hour
time point were inoculated via the ip route into female three-week-
old NIH Swiss mice to test for virulence characteristics of the virus.
Sporadic mortality was observed at multiple doses of virus (less
than 50% mortality per dose), and no dose was associated with either
uniform mortality or survival. Brains were taken from four represen-
tative mice that had clinical signs of WNV disease, and viral RNA was
isolated and sequenced. Upon sequencing of the NS4B region, viral
RNA from two of the mice was found to encode an additional NS4B
A95T substitution in addition to the original P38G and T116I substitu-
tions. Viral RNA from the brain of a third mouse encoded an addition-
al NS4B V110A mutation while viral RNA isolated from the fourth
mouse brain encoded an additional I224V mutation. Upon analysis
of the consensus sequencing chromatogram from the original 96-Table 3
Temperature sensitive and mouse virulence phenotypes of P38G/T116I/N480H-derived viru
Virusc Temperature sensitivitya
Viral titer/mL at
37 °C (log10pfu)
Viral titer/mL at
41 °C (log10 pfu)
Rela
[log1
NY99 7.2 7.0 −0.
P38G/T116I/
N480H
6.7 3.4 −3.
+A83S 4.7 3.4 −1.
+A95T 5.0 4.6 −0.
+A100V 5.5 5.1 −0.
+V110A 5.1 4.7 −0.
+I224V 4.6 4.3 −0.
a Virus seeds were plaque titrated in Vero cells under agar overlay at 37 °C and 41 °C. The
ature indicates the degree of temperature sensitivity.
b Median lethal viral dose (LD50) following intraperitoneal (i.p.) administration of virus.
c Infectious clone-derived wild-type NY99 WNV, attenuated P38G/T116I/N480H virus, a
+A83S=alanine-to-serine mutation at amino acid residue NS4B-83 in addition to NS4B P3hour 41 °C virus sample, heterogeneity was observed at nucleotides
G/A7198 corresponding to residue 95 and T/C7244 corresponding
to residue 110, but not at position A7585 corresponding to residue
224, indicating a mixed population of viruses at the 96-hour time
point following incubation in Vero cells at 41 °C (data not shown).
To identify any additional mutations within the NS4B region
that may have been selected during multiplication at 41 °C, eight
plaques were harvested from virus at the 96-hour time point at
41 °C. Nucleotide sequencing of the NS4B region of these eight
plaques revealed four isolates encoding the I224V substitution, and
one isolate each encoding the following substitutions: A83S, A95T,
A100V, and V110A. Thus, A95T, V110A, and I224V substitutions
were identiﬁed both in plaque picks from the 96-hour time point
sample in cell culture and in mouse brain, while A83S and A100V
substitutions were identiﬁed only by plaque picking. Virus encoding
either a direct G38P or I116T reversion was never detected.Analysis of compensatory mutants
Viruses containing the engineered P38G/T116I/N480H substitu-
tions in addition to a putative compensatory substitution (i.e., either
A83S, A95T, A100V, V110A, or I224V) were analyzed to determine if
the temperature-sensitive and/or mouse neuroinvasive-attenuated
phenotypes of the parental virus were conserved. Viruses encoding
A95T, A100V, V110A, or I224V substitutions in addition to P38G/
T116I/N480H were found to be no longer temperature-sensitive in
Vero cells at 41 °C with less than a 1 log10 decrease in titer at 41 °C
compared to 37 °C, but all multiplied to a lower titer than the wild-
type virus at 37 °C (Table 3). The P38G/T116I/N480H+A83S virus
was found to be slightly temperature-sensitive with a 1.3 log10 pfu/
mL decrease in titer 41 °C versus 37 °C, although this virus was less
temperature-sensitive than the parental P38G/T116I/N480H virus
and below the 2.0 log10 pfu/mL decreased level denoted as signiﬁcant.
Viruses encoding the putative compensatory substitutions in addition
to the P38G/T116I/N480H substitutions were inoculated into three-
week-old female NIH Swiss mice via the ip route. Viruses encoding
additional A95T, A100V, V110A, and I224V substitutions were found
to exhibit mouse-neuroinvasive virulent phenotypes with ip LD50
values greater than one million-fold lower than observed for the
attenuated P38G/T116I/N480H parental virus (Table 3). The P38G/
T116I/N480H/A83S virus was found to retain an attenuated pheno-
type with an ip LD50 value of greater than 1000 pfu. Each P38G/
T116I/N480H-derived virus that encoded an additional NS4B compen-
satory substitution was subjected to complete genomic sequencing,
and each virus had the A6049C nucleotide change encoding an NS3
N480H amino acid substitution.ses encoding compensatory substitutions.
Mouse virulenceb
tive change in viral titer
0(pfu41C/pfu37C]
i.p. LD50 (pfu) i.p. AST (days±SD)
2 0.7 7.2±0.4
3 >10,000,000 >35
3 >1000 >21
4 2.0 8.8±0.8
4 8.0 11±1.2
4 4.0 9.6±1.3
3 5.0 11±2.0
relative change [log10 (titer at 41 °C/titer at 37 °C)] in viral titer at the higher temper-
AST=average survival time.
nd P38G/T116I/N480H-derived viruses encoding additional amino acid substitutions.
8G, T116I , and NS3 N480H substitutions.
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passaged in Vero cells at 37 °C or 41 °C
To better understand the signiﬁcance of the observed compen-
satory substitutions, viral RNA was isolated from the parental
P38G/T116I/N480H virus that had been passaged once in Vero
cells post-transfection plus virus samples taken from Vero cell
supernatants at 96 h post-infection at 37 °C and 41 °C. Viral RNA
was subjected to RT-PCR utilizing NS4B-speciﬁc primers, and PCR
products were sequenced directly to obtain the consensus sequence.
In addition, PCR products were cloned and 21–23 clones were
sequenced for each product to assay the prevalence of nucleotide
changes and deduced amino acid substitutions. The basal variability
of the parental P38G (nucleotide substitutions C7027G and
C7028G)/ T116I (nucleotide substitution C7262T) viral RNA was an-
alyzed and compared to the selection of speciﬁc mutants following
96 h in Vero cells at either 37 °C or 41 °C. Cloned PCR fragments
from the parental P38G/T116I/N480H virus were found to exhibit
few differences with 3/22 (14%) sequenced fragments exhibiting
nucleotide changes and 1/22 (5%) fragment encoding an amino
acid substitution (Table 4). Two parental cDNA clones exhibited
silent nucleotide changes, and a single cDNA clone encoded a H58Y
(C7087T) amino acid substitution. In contrast, 22/23 (96%) cDNA
clones from the 96-hour 41 °C virus sample exhibited nucleotide
changes leading to amino acid substitutions. Fifteen of 23 (65%)
sequenced clones encoded the A95T (G7198A) substitution, 4/23
(17%) encoded the A100V (C7214T) substitution, 2/23 (9%) encoded
the I224V (A7585G) substitution, and 1/23 (4%) encoded a R84Q
(G7166A) substitution. In addition, T48A (A7057G), L56P (T7056C),
V155I (G7378A), I168V (A7414G), and C227R (T7594C) substitutions
were each detected in one cDNA clone (4% prevalence) from the
96-hour 41 °C virus and occurred in conjunction with either an
A95T or A100V substitution (Table 4). Seven of 23 (30%) cDNA
clones exhibited additional silent nucleotide changes in addition
to encoding amino acid substitutions. Sequenced cDNA clonesTable 4
Analysis of the mutation rate of the NS4B gene of P38G/T116I/N480H virus during replicatio
stock.
cDNA
clone no.b
Parental P38G/T116I virusa 37 °C 96-hour virus
Nucleotide change Amino acid change Nucleotide change
1 – –c –
2 – – –
3 T7015C – G7564A*
4 – – G7080A
5 C7087T* H58Y –
6 – – –
7 – – G7080A, A7240G*, A7648G
8 – – –
9 – – –
10 – – A7218G
11 – – –
12 – – –
13 – – –
14 – – A7481G*
15 – – –
16 – – –
17 – – –
18 – – A7240G*, A7648G*
19 – – –
20 – – T7262C*, A7444T*
21 A7554G – –
22 – – N.A.
23 N.A. N.A. N.A.
*d=nucleotide mutation(s) that encode the shown amino acid mutation(s).
a Parental virus passaged once in Vero cells following the initial derivation by transfectio
b RT-PCR-ampliﬁed cDNA containing the NS4B gene was cloned into a plasmid vector in E.
presence of non-engineered mutations.
c –=no nucleotide mutation detected in the cloned NS4B gene fragment.from the 96-hour 37 °C virus sample yielded an intermediate
frequency of substitutions with 7/21 (33%) exhibiting nucleotide
changes and 5/21 (24%) encoding amino acid substitutions. Two
of 21 (10%) clones were found to encode T109A (A7240G) and
I245V (A7648G) substitutions. One clone of 21 (5%) encoded a
V217I (G7564A) substitution, and another (1/21; 5%) encoded a
N189S (A7481G) substitution. Finally, one clone (5%) was found
to lack the parental T116I substitution, but this clone encoded
an additional M177L (A7444T) substitution. Overall, a total of 50
nucleotide changes were found in 66 cDNA clones that were
sequenced, and 49/50 (98%) were transition mutations. The single
A7444T transversion led to the deduced M177L amino acid substi-
tution in the only fragment lacking the parental T116I (C7262T)
substitution. Three of 50 (6%) nucleotide changes occurred in cDNA
clones from the parental virus, 36/50 (72%) occurred in clones from
the 96-hour 41 °C virus, and 11/50 (22%) occurred in clones from
the 96-hour 37 °C virus.
RNA and protein levels in wild-type and P38G/T116I/N480H virus-infected
Vero cells
To investigate the block in viral replication with respect to the
multiplication of P38G/T116I/N480H virus at 41 °C, intracellular
viral RNA and protein levels were assayed in Vero cells at both 37 °C
and 41 °C. Quantitative real-time RT-PCR indicated that levels
of viral RNA synthesis for both wild-type and P38G/T116I/N480H
viruses were within 100-fold of each other in Vero cells at 37 °C
during all time points (Fig. 3A, left panel). In contrast, there was a
sharp reduction in synthesis of viral RNA levels in P38G/T116I/N480H
virus-infected cells compared to wild-type virus-infected cells
(decreases between 1000-fold and 10,000-fold) at 41 °C (Fig. 3A, right
panel). Viral protein levels were measured by Western blot utilizing a
rabbit anti-WNV E protein domain III antiserum to probe cell lysates
generated from virus-infected Vero cells. Viral E protein (~50 kDa
band) levels for both wild-type and P38G/T116I/N480H virus-infectedn in Vero cells at either 37 °C or 41 °C compared to sequence variability in the parental
41 °C 96-hour virus
Amino acid change Nucleotide change Amino acid change
– A7158G, G7198A*d, G7378A* A95T, V155I
– T7015C, C7214T* A100V
V217I G7198A* A95T
– G7198A*, T7488C, A7554G A95T
– G7198A* A95T
– G7198A* A95T
* T109A, I245V G7198A* A95T
– G7198A* A95T
– G7198A* A95T
– G7198A* A95T
– C7214T*, A7227G A100V
– T7015C, C7214T*, T7594C* A100V, C227R
– G7166A* R84Q
N189S G7198A* A95T
– G7198A*, C7410T, A7417G* A95T, I168V
– A7005G, G7198A*, T7488C A95T
– A7585G* I224V
T109A, I245V G7198A* A95T
– G7198A* A95T
I116T, M177L A7057G*, C7214T* T48A, A100V
– – –
N.A. A7585G* I224V
N.A. T7056C*, G7198A* L56P, A95T
n.
coli. The nucleotide sequences of 21 or 23 individual NS4B clones were analyzed for the
Fig. 3. Viral RNA (A) and protein (B) levels from cell lysates of wild-type and P38G/T116I/N480H mutant infected cell cultures incubated at 37 °C and 41 °C. (A) TaqMan quantitative
real-time RT-PCR was conducted on total cellular RNA preparations using primers localizing to the WNV 3′-UTR. Data were converted to pfu equivalents (PEQ) utilizing a standard-
ized curve. (B) Protein levels were assayed from crude cellular lysates, and Western blots were probed for WNV E protein (~50 kDa band) with rabbit anti-E domain III polyclonal
antibody. β-actin (~45 kDa band) levels were used as an internal standard.
29J.A. Wicker et al. / Virology 426 (2012) 22–33cells were similar at 37 °C, while viral protein levels were sharply
reduced in P38G/T116I/N480H virus-infected cells compared to wild-
type virus-infected cells at 41 °C (Fig. 3B). β-actin (~45 kDa band)
was used as an internal standard, and these protein levels were similar
in all samples.
Discussion
In this study we have investigated the role of various amino acid
substitutions in the NS4B protein and their role in a number of pheno-
typic properties of WNV. These engineered mutations were focused
on a highly conserved N-terminal motif and a central hydrophobic
region. Targeted N-terminal residues are highly conserved through-
out both tick-borne and mosquito-borne ﬂaviviruses. In contrast,
those targeted to the central hydrophobic region are less conserved
and exhibit signiﬁcant variability throughout the Flavivirus genus,
but have been reported to be involved in phenotypic properties of
other ﬂaviviruses. In particular, there is evidence to suggest that
the central region of NS4B plays a role in the virulence phenotype of
ﬂaviviruses (Hanley et al., 2003; McArthur et al., 2003; Wicker et al.,
2006). Most engineered substitutions were well-tolerated, even
those corresponding to positions found to confer altered growth phe-
notypes in other ﬂaviviruses. Only one of nine recombinant mutant
viruses tested exhibited an attenuated phenotype in mice. This mu-
tant, containing an engineered P38G substitution and an additional
T116I substitution, was found to exhibit small-plaque morphology,
temperature sensitivity at 41 °C, and attenuation of neuroinvasiveness
in mice.
The P38G/T116I/N480H mutant exhibited at least 10,000,000-fold
attenuation for neuroinvasiveness when inoculated via the ip route,
yet was as neurovirulent as wild-type WNV when injected via the icroute. Previously, we reported a recombinant WNV virus containing
an NS4B C102S substitution that was highly attenuated for both
neuroinvasiveness and neurovirulence (Wicker et al., 2006). The
difference in neurovirulence phenotypes between the two attenuated
mutants implies that mouse neuroinvasiveness and neurovirulence
phenotypes are encoded by different molecular determinants. In ad-
dition, while the P38G/T116I/N480H virus exhibited small-plaque
morphology, the C102S virus had a large-plaque phenotype. Both
viruses were found to be temperature-sensitive at 41 °C although
the phenotype was more severe with the C102S virus. The C102
residue resides within the central hydrophobic region that was also
targeted in this study suggesting that while most substitutions are
well-tolerated, some can signiﬁcantly alter virulence and multiplica-
tion phenotypes.
The engineered P38G substitution is primarily responsible for ob-
served differences in phenotypes as mutants containing NS4B T116I
(Table 1A) or NS3 N480H (Table 1B) alone exhibited multiplication
and virulence phenotypes similar to those of wild-type WNV, as did
the mutants encoding additional NS4B compensatory substitutions
(Table 3). The viremia curve showed that the P38G/T116I/N480H
virus attained signiﬁcant serum titers but did not successfully invade
the brain (Table 2). It is hypothesized that the attenuated mutant
never reached sufﬁciently high titers to cross the blood–brain barrier.
This is further supported by the observation of a highly neurovirulent
phenotype following ic inoculation of the P38G/T116I/N480H mutant
demonstrating that this virus is fully capable of causing disease
following introduction into the central nervous system. Virulent
WNV strains have previously been associated with increased viremias
and mortality in crows, while attenuated viruses tend to produce
lower viremias and concurrent increases in survival (Brault et al.,
2007; Kinney et al., 2006). However, it has also been demonstrated
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not always result in signiﬁcant mortality in mice (Brown et al., 2007;
Wicker et al., 2006).
Given that virus encoding only the P38G substitution was never
isolated following multiple transfection attempts, an additional
substitution (such as T116I) may be required for the viability of the
virus. To further address this possibility, a P38A substitution was
engineered. The resulting recombinant virus did not encode T116I
or any additional substitutions, nor did it encode temperature sensi-
tive or mouse attenuated phenotypes. This was expected as the
Brazilian ﬂavivirus Ilheus encodes an alanine at the homologous
residue suggesting that this substitution would be tolerated
(Figueiredo, 2000). It is possible that increased ﬂexibility introduced
by the glycine residue near the putative N-terminal membrane inser-
tion point (see Fig. 2) disrupted the normal conformation provided by
proline while the alanine substitution may preserve the natural
conformation thereby ablating the need for additional compensatory
substitutions. In addition it was found that the attenuated phenotype
conferred by the P38G substitution could be compensated by a variety
of additional substitutions. Multiplication of the P38G/T116I/N480H
virus at 41 °C resulted in identiﬁcation of variants containing compen-
satorymutations at the 96-hour time point sample. Viruses containing
A95T, A100V, V110A, or I224V substitutions in addition to the original
P38G and T116I substitutions exhibited mouse virulence characteris-
tics similar to wild-type WNV and were no longer temperature-
sensitive. However, a virus containing an additional A83S substitution
was still attenuated for neuroinvasiveness in mice and exhibited
a temperature-sensitive phenotype in Vero cells at 41 °C; although
this virus was less temperature-sensitive than the parental P38G/
T116I/N480H virus. These data suggest that the same underlying
mechanism may be responsible for both the temperature-sensitive
phenotype in cell culture and the neuroinvasive phenotype in mice.
Full-length genomic sequencing was conducted on the P38G/T116I/
N480H virus as well as P38G/T116I/N480H derived strains encoding
compensatory substitutions, and only the NS3 N480H mutation was
observed outside of the NS4B region. While the attenuated phenotype
of the P38G/T116I/N480H virus was reversed by a variety of compen-
satory mutations, a direct G38P revertant was never detected; rather,
the engineered substitution appeared to be quite stable. This is pre-
sumably due to the engineered glycine differing from proline by two
adjacent transversion nucleotide changes (C7027G and C7028G),
such that direct reversion would be a rare event. Interestingly, the
proline did not mutate to an alanine, which would only require a
single nucleotide change, however, this may be due to the presence
of the T116I substitution. This is in marked contrast to the previously
described C102S (G7220C) virus, where direct S102C (C7220G) rever-
tants (a single nucleotide change) were associated with reversal of
temperature-sensitive and mouse attenuation phenotypes (Wicker
et al., 2006). Each of the compensatory mutations associated with
the engineered P38G virus (A83S (G7162T), A95T (G7198A), A100V
(C7214T), V110A (T7244), T116I (C7262T), I224V (A7585G)) repre-
sents a single nucleotide change. It is not entirely clear how the
compensatory substitutions exert their effects. None of the compensa-
tory mutations were highly conserved among the mosquito-borne
ﬂaviviruses. The NS4B A83S substitution has been found to occur
naturally in a WNV strain isolated from human plasma in Ohio in
2002 (Davis et al., 2005). In addition, the related naturally mouse-
attenuated Rabensburg virus differs from the NY99 strain of WNV at
positions A95S, A100V, and T116A (Bakonyi et al., 2005). A lineage 2
isolate from Nigeria also encodes A100V and T116A substitutions
while an attenuated lineage 2 strain from Madagascar (MAD78) en-
codes the T116I substitution, although it is unlikely that this mutation
is directly responsible for the attenuation of the virus (Keller et al.,
2006; Yamshchikov et al., 2001). In contrast, the V110 and I224 resi-
dues are highly conserved in all WNV isolates analyzed to date but
not in other members of the JE serogroup.Putative compensatory substitutions such as T116I, M177L, A95T,
A100V, V100A, and I224V may restore the ability of the NS4B protein
to assemble and function properly. Yu et al. have shown that there are
molecular determinants in both N-terminal and C-terminal regions
of the Hepatitis C virus (HCV) NS4B protein that may inﬂuence the
ability of NS4B to polymerize (Yu et al., 2006). In addition, it has
been shown that substitutions in predicted ER-lumenal regions of
the NS4B protein can nearly abolish HCV replicon colony formation
although these regions are thought to be separate from the cytoplas-
mic components of the replication complex (Lindstrom et al., 2006).
This is further support for the hypothesis that the NS4B protein may
form either oligomers or crucial complexes with certain cellular pro-
teins. While HCV NS4B displays little sequence homology with WNV
NS4B, it is thought that these proteins may exhibit similar topologies
and functions within the cell (Lundin et al., 2003;Welsch et al., 2007).
The P38 residue is predicted to localize to the junction of an ER-
lumenal region and a transmembrane domain, and it will be critical
to elucidate potential protein–protein interactions to better explain
the temperature sensitive and mouse attenuation phenotypes ob-
served in conjunction with disruption of this residue.
The results reported in this study begin to identify the interacting
network of residues in WNV NS4B that are essential in maintaining
the life cycle of wild type NY99 WNV. In the absence of atomic struc-
tural information of NS4B, one cannot provide an accurate interpreta-
tion of the current data. However, the data unequivocally establish
the presence of long range interactions among various putative struc-
tural elements in NS4B. Regardless of the algorithm used in predicting
the secondary structures, including the transmembrane domains,
there is a consensus that the N-terminal residues reside in the ER
lumen and the other key residues involved in this study, e.g. 83, 95,
100, 110, 116 and 224, are located in transmembrane domain(s)
(Miller et al., 2007). Thus, residue 38 obviously resides at a distance
from the residues that are located in transmembrane domains. It is
possible to eliminate a direct pairwise interaction between residue
38 and the others as the likely mechanism to confer compensatory
effects as reported in this study. One possible mechanism is the alter-
ation of pairwise interaction between the mutated side-chains and
other residues between these putative transmembrane domains.
The proof of this mechanism will require the atomic structure of
NS4B. Another possibility is that these side-chain substitutions affect
the stability of the transmembrane domains (Adamian and Liang,
2001). It has been shown that a single amino acid replacement can
affect the stability of a transmembrane domain and as a consequence
leading to a disease state (Li et al., 2006). In addition to compensatory
mutations observed within the NS4B protein, a NS3 N480H substitu-
tion was present in all P38G-derived viruses. Second-site mutations
have also been identiﬁed within the NS3 protease region of GBV-B
RNAs containing NS4B C-terminal HCV amino acid sequences, pro-
viding evidence for interaction between NS3 and NS4B during repli-
cation (Benureau et al., 2010). The dengue NS4B protein has also
been shown to interact with NS3, and it is possible that the engi-
neered WNV NS4B P38G substitution induced the second-site NS3
N480H mutation to preserve the potential for productive interaction
during replication (Umareddy et al., 2006). Thus, an understanding
of the molecular mechanism of structure–function correlation of
NS4B and potential interactions with other host and viral products
requires further biophysical studies on the structure and energetics
among these elements.
Materials and methods
Site-directed mutagenesis
The 3′ plasmid of the WNV infectious clone WN/IC P991 served
as the template for introduction of mutations (Beasley et al.,
2005; Kinney et al., 2006). Mutagenesis was conducted using
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following the manufacturer's protocol. Sets of primers were designed
for each engineered mutation (D35E, P38G, P38A, W42F, Y45F, L97M,
A100V, L108P, T116I) including sufﬁciently long ﬂanking regions to
obtain a predicted melting temperature of at least 78 °C. Primer
sequences are available upon request. Mutagenesis reactions were car-
ried out in a thermocycler following speciﬁc cycling parameters listed in
the manufacturer's protocol. Products were then digested with DpnI to
remove parental DNA and transformed into XL-10 Gold ultracompetent
cells that were plated on Luria-Bertani/ampicillin plates. Four colonies
from each mutagenesis reaction were isolated, and plasmid DNA was
puriﬁed utilizing the GenElute Plasmid Miniprep kit (Sigma). Sequenc-
ing was conducted to conﬁrm the presence of the desired mutation and
absence of additional mutations in the NS4B gene. Appropriate plas-
mids were grown in 200 mL cultures to obtain concentrated DNA for
further manipulation.
Construction and transfection of recombinant viruses
The WNV NY-99 infectious clone was constructed in two plasmids
(Beasley et al., 2005; Kinney et al., 2006). Three micrograms each of
5′ pWN-AB and 3′ pWN-CG infectious clone plasmids were digested
simultaneously with NgoMIV and XbaI restriction enzymes (New
England Biolabs). Appropriate DNA fragments were visualized on an
agarose gel and puriﬁed using a Qiaquick gel extraction kit (Qiagen).
Fragments were ligated overnight at room temperature using T4 DNA
ligase (NEB). DNA was linearized by digesting with XbaI, treated with
Proteinase K (Roche), and extracted twice with phenol/chloroform/
isoamyl alcohol and once with chloroform. DNA was ethanol precipi-
tated, and the pellet was resuspended in TE buffer. The resulting
product served as the template for transcription using a T7 Ampli-
scribe kit (Epicentre) and A-cap analog (NEB). Following a 3-hour in-
cubation at 37 °C, the transcription reaction was added to 1.5×107
African green monkey kidney Vero cells suspended in 500 μL PBS,
and transfection was accomplished using electroporation. The cells
were placed in a cuvette (0.2 cm electrode gap) on ice, pulsed twice
at 1.5 kV, inﬁnite Ohms, and 25 μF, incubated at room temperature
for 10 min, transferred to 75-cm2 ﬂasks containing MEM with 8%
FBS, and incubated at 37 °C and 5% CO2. Viruses were harvested on
day 5 or 6 post-transfection, when CPE was evident. Culture medium
containing virus was clariﬁed by centrifugation for 5 min at 12,000 g,
and 1-mL aliquots were stored at −80 °C. Viral RNA was extracted
using the QIAamp Viral RNA Mini-Spin kit (Qiagen). The presence of
the engineered NS4B mutation was conﬁrmed by amplifying the
NS4B region using the Titan One-Step RT-PCR kit (Roche) and DNA
sequencing. Full-length genomic sequencing was conducted of the
P38G/T116I/N480H mutant virus to check for additional mutations.
Plaque and temperature sensitivity assays
Infectivity titers of recombinant viruses were determined by
plaque titration in Vero cells at both 37 °C and 41 °C. Vero cells
were allowed to grow to approximately 90% conﬂuency in six-well
plates. Growth medium (MEM with Earle's salts and L-glutamine
(Gibco) supplemented with 8% fetal bovine growth serum (FBS)
(Hyclone), 100 units/mL penicillin (Gibco), and 100 μg/mL strepto-
mycin (Gibco) was removed, and cells were rinsed with phosphate
buffered saline (PBS-Gibco). Serial dilutions of each virus were
adsorbed, 200 μL per well, for 30 min before overlaying the cell
monolayer with a 50:50 mixture of 2% agar (Sigma) and 2× MEM
(Gibco) containing 4% FBS. Two days following the ﬁrst agar overlay,
2 mL of a mixture of 2% agar and 4% FBS 2× MEM containing 2% neu-
tral red was added to each well. Plaques were visualized and counted
the following day, and viral infectivity titers were calculated. Viruses
found to be temperature sensitive at 41 °C (i.e., a >100-fold reductionof efﬁciency of plaquing compared to that at 37 °C) were plaqued at
39.5 °C to better deﬁne the temperature sensitive phenotype.
Mouse virulence studies
Recombinant viruses were diluted in PBS, and 10-fold serial
doses ranging from 103 pfu to 10−1 pfu were injected by ip route in
a volume of 100 μL into groups of ﬁve 3–4 week old female NIH
Swiss mice (Harlan). Clinical signs of infection such as rufﬂed fur or
hunched posture were noted during the following 14 days, and
the LD50 value was calculated for each virus. Three weeks following
inoculation, surviving mice were challenged intraperitoneally with a
uniformly lethal dose (100 LD50) of wild-type NY-99 WNV to deter-
mine if they had developed a protective immune response. If a virus
was found to be attenuated via the ip route, serial 10-fold doses
were administered to isoﬂuorane anesthetized 3–4 week old mice in
a 20 μL volume via the intracerebral (ic) route to investigate the
mouse neurovirulence phenotype.
Virus multiplication in cell culture
Growth curves were conducted for wild-type WNV and the
mutant viruses in monkey kidney Vero cells at both 37 °C and 41 °C,
in mouse neuroblastoma Neuro2A cells at 37 °C, and in mosquito
C6/36 cells at 28 °C. Cells were grown in six-well plates in appropriate
media and were infected with 200 μL of virus diluted in PBS at a
moi of 0.01. After adsorbing virus for 30 min, the cells were washed
three times with PBS, and 4 mL of the appropriate medium was
added. At various timepoints following infection, 0.5 mL samples
were removed and frozen at −80 °C. The harvested samples were
then plaque titrated in twelve-well plates of Vero cells. Vero
cells were grown in MEM with Earle's salts and L-glutamine (Gibco)
supplemented with 8% FBS, 100 units/mL penicillin, and 100 μg/mL
streptomycin. Neuro 2A cells were grown in MEM with Earle's salts
and L-glutamine supplemented with 8% FBS, 100 units/mL penicillin,
100 μg/mL streptomycin, 0.075% sodium bicarbonate (Sigma), and
1 mM sodium pyruvate (Sigma). C6/36 cells were grown in MEM
with Earle's salts and L-glutamine supplemented with 8% FBS
(Hyclone), 100 units/mL penicillin, 100 μg/mL streptomycin, and
0.075% tryptose phosphate broth.
Virus multiplication in mice
Female 3–4 week old NIH Swiss mice were inoculated with 100
pfu of either wild-type WNV or P38G/T116I/N480H virus via the ip
route. Three mice were sacriﬁced for each virus per day for 6 days.
Blood was collected by cardiac puncture, and brains were harvested.
Brains were homogenized by repeated pipetting in 0.5 mL MEM
media supplemented with 8% FBS, and centrifuged homogenate su-
pernatants were subjected to plaque assays to determine infectivity
titers in the brain. The limit of detection was 2.7 log10 pfu/brain.
Viral RNA was also isolated from brains using the Viral RNA Mini
Spin kit (Qiagen) and ampliﬁed by RT-PCR utilizing the Titan kit
(Roche) to detect low levels of virus in the brain below the level of
detection for plaque assays. Blood from cardiac puncture was spun
down, and serum was removed and frozen. Serum samples were
plaque assayed to determine viral titers, and the limit of detection
was 1.7 log10 pfu/mL.
Analysis of quasispecies in viral-RNA with respect to compensatory
substitutions
Viral RNA was isolated from the parental P38G/T116I/N480H
viral stock in addition to virus samples from the 96-hour time
point in Vero cells incubated at either 37 °C and 41 °C utilizing the
Qiagen RNeasy mini kit. RT-PCR was conducted on the 96-hour
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speciﬁc primers, and PCR products were cloned into the T-easy vec-
tor (Promega). Resulting plasmids were transformed into E. coli
DH5α cells and selected on LB/ampicillin plates. Twenty-one to 23
colonies each were picked from the parental sample used to infect
Vero cell cultures, 96-hour 37 °C sample, and 96-hour 41 °C sample.
The NS4B region was sequenced for each cDNA clone, and frequencies
of nucleotide and encoded amino acid substitutions for the cDNA
clones from each of the three samples were determined.Quantitative real-time RT-PCR and Western blots
Virus-infected Vero cell monolayers (moi of 0.01) were rinsed
three times with PBS, and total viral and cellular RNA was isolated
from cellular lysates at 0, 12, 24, and 48 h post-infection by using
the Qiagen RNeasy Mini kit. A ~100-bp fragment of the 3′ noncoding
region was ampliﬁed using TaqMan one-step RT-PCR as described by
Vanlandingham et al. (2004) using a primer set ﬁrst described by
Lanciotti et al. (2000). RNA levels were quantiﬁed by comparison to
a standard curve generated from serial 10-fold dilutions of WNV
RNA isolated from a virus stock of known infectivity titer resulting
in values expressed as pfu equivalents. To determine protein levels,
cell lysates were generated by solubilizing virus- or mock-infected
Vero monolayers in 0.5 mL of RIPA buffer containing 1% SDS. Equal
volumes (8 μL) of each lysate were run in 12.5% SDS-PAGE gels and
transferred to PVDF membranes in duplicate. One membrane was
probed with rabbit polyclonal anti-WNV envelope domain III anti-
body to determine viral E protein levels, while the other membrane
was probed with mouse anti-β-actin antibody (Sigma) to assay cellu-
lar protein levels.Acknowledgments
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